Ma Kuang Healthcare Holding (4139) Fair Value & Analysis
Healthcare · TW · Market cap 1.9B TWD
Fair value as of: Jul 23, 2026
From 13 valuation models · updated 18 days ago
Share price +46.2% over the past month.
Below-average quality, screening 40% undervalued on our models.
What matters now
- The price is below even our cautious bear case (39.88 TWD). The market is more pessimistic than our downside scenario.
- Solid quality (48/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 23, 2026.
How to read this chart
60‑month range 21.85 TWD – 56.61 TWD · fair‑value band 39.88 TWD – 69.67 TWD · the 36.40 TWD price screens below the 50.82 TWD fair value. Dashed = 300-day average. As of Jul 23, 2026.
Analysis
Ma Kuang Healthcare Holding (4139) currently trades at 36.40 TWD, while our model-based Fair Value estimate is 50.82 TWD, implying the stock looks roughly 39.6% undervalued today. The Quality Score stands at 48/100 (below-average quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium), always confirm before acting.
Over the trailing twelve months, Ma Kuang Healthcare Holding generated revenue of 1.1B TWD at a net margin of -7.3%. Revenue declined 3.6% year over year. It earns a return on equity of -19.6%. Net debt stands at 286M TWD. Fundamentals as of Jul 23, 2026
Our scenario range runs from 39.88 TWD (bear case) to 69.67 TWD (bull case); at 36.40 TWD, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 73% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 40%, 4139 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 13 models by family
Widest divergence: Multiples (61.40 TWD) versus Asset-Based (6.58 TWD). Highest evidence: Growth DCF (80).
Notify me when 4139 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 73
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan, Singapore, Mainland China, and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc.
Full company description
Ma Kuang Healthcare Holding Limited, an investment holding company, provides medical services in Taiwan, Singapore, Mainland China, and internationally. The company offers community medical services, Chinese medical services, Chinese medicines, medical management training courses, educational support services, etc. It also provides medical treatment, and overseas student homestay and guardianship services; management consultant services; Chinese medicine beauty services; consulting services, such as corporate management, computer technology, industry information, and marketing; and e-commerce sales services. In addition, the company operates clinics, educational institutions, community medicine clinics, and traditional Chinese medicine clinics. Further, it is involved in sale of dietary supplement, and pharmaceutical and medical goods in stores; restaurant business; and leasing and other services. The company was incorporated in 2009 and is based in Kaohsiung, Taiwan.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Ma Kuang Healthcare Holding reported revenue of 1.1B TWD in FY2025 versus 959M TWD in FY2021, a compound +3.3%/yr. Reported net income was −67.1M TWD in FY2025.
Watch 4139: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 23, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Ma Kuang Healthcare Holding with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Ma Kuang Healthcare Holding (4139) overvalued or undervalued?
What is the fair value of 4139?
What is the quality score of 4139?
What is the revenue of Ma Kuang Healthcare Holding (4139)?
What is the net profit margin of 4139?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Ma Kuang Healthcare Holding and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.